Skip to main content
Clinical Trials/CTRI/2016/04/006889
CTRI/2016/04/006889
Completed
Phase 4

Role of flupertine as a perioperative analgesic in patients undergoing spinal surgery: A prospective, randomized controlled study

Apollo Hospitals Bilaspur0 sites70 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Apollo Hospitals Bilaspur
Enrollment
70
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
April 20, 2017
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.ASA grade I and II
  • 2\.Non hypertensive and non diabetic
  • 3\.Scheduled for spinal surgery under general anesthesia

Exclusion Criteria

  • 1\.Patients with known sensitivity to study drugs
  • 2\.History of drug or alcohol abuse,
  • 3\.Morbid obesity (body mass index \>40\),
  • 4\.History of chronic pain or daily intake of analgesics
  • 5\.Oral anticoagulant use (warfarin)
  • 6\.Patients with bleeding diathesis
  • 7\.Impaired kidney or endocrinal functions
  • 8\.Pregnant patients and
  • 9\.Psychiatric patients

Outcomes

Primary Outcomes

Not specified

Similar Trials